Microcirculation: Structural and functional specificities

Microcirculation and Insulin Resistance

Volumn , Issue , 2009, Pages 1-13

  Bouskela, Eliete ^a   Bottino, Daniel ^a   Wiernsperger, Nicolas ^a,b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860474761     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805057410901010001     Document Type: Chapter

References (139)

1. Pohl U, De Wit C, Gloe T. Large arterioles in the control of blood flow: role of endothelium-dependent dilation. Acta Physiol Scand 2000 Apr; 168(4): 505-10.
2. Souza FM, Padilha AS, Stefanon I, Vassallo DV. Differences in functional and structural properties of segments of the rat tail artery. Braz J Med Biol Res 2008 May; 41(5): 416-23.
3. Thijssen DH, Dawson EA, Black MA, Hopman MT, Cable NT, Green DJ. Heterogeneity in conduit artery function in humans: impact of arterial size. Am J Physiol Heart Circ Physiol 2008 Nov; 295(5): H1927-34.
4. McAllister RM. Endothelium-dependent vasodilation in different rat hindlimb skeletal muscles. J Appl Physiol 2003 May; 94(5): 1777-84.
5. dela Paz NG, D'Amore PA. Arterial versus venous endothelial cells. Cell Tissue Res 2009 Jan; 335(1): 5-16.
6. Jackson CJ, Nguyen M. Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol 1997 Oct; 29(10): 1167-77.
7. Sandow SL, Haddock RE, Hill CE, Chadha PS, Kerr PM, Welsh DG, et al. What'S where and why at a vascular myoendothelial microdomain signalling complex. Clin Exp Pharmacol Physiol 2009 Jan; 36(1): 67-76.
8. Davis MJ. Myogenic response gradient in an arteriolar network. Am J Physiol 1993 Jun; 264(6 Pt 2): H2168-79.
9. Tooke JE. Capillary hypertension and microvascular complications. Transplant Proc 1994 Apr; 26(2): 373-4.
10. Pries AR, Secomb TW. Origins of heterogeneity in tissue perfusion and metabolism. Cardiovasc Res 2009 Feb 1; 81(2): 328-35.
11. Berg BR, Cohen KD, Sarelius IH. Direct coupling between blood flow and metabolism at the capillary level in striated muscle. Am J Physiol 1997 Jun; 272(6 Pt 2): H2693-700.
12. Collins DM, McCullough WT, Ellsworth ML. Conducted vascular responses: communication across the capillary bed. Microvasc Res 1998 Jul; 56(1): 43-53.
13. Ellis CG, Wrigley SM, Groom AC. Heterogeneity of red blood cell perfusion in capillary networks supplied by a single arteriole in resting skeletal muscle. Circ Res 1994 Aug; 75(2): 357-68.
14. Lo A, Fuglevand AJ, Secomb TW. Oxygen delivery to skeletal muscle fibers: effects of microvascular unit structure and control mechanisms. Am J Physiol Heart Circ Physiol 2003 Sep; 285(3): H955-63.
15. Kayar SR, Banchero N. Sequential perfusion of skeletal muscle capillaries. Microvasc Res 1985 Nov; 30(3): 298-305.
16. Slaaf DW, Oude Egbrink MG. Capillaries and flow redistribution play an important role in muscle blood flow reserve capacity. J Mal Vasc 2002 Apr; 27(2): 63-7.
17. Lindbom L, Arfors KE. Mechanisms and site of control for variation in the number of perfused capillaries in skeletal muscle. Int J Microcirc Clin Exp 1985; 4(1): 19-30.
18. Clark MG, Rattigan S, Barrett EJ. Nutritive blood flow as an essential element supporting muscle anabolism. Curr Opin Clin Nutr Metab Care 2006 May; 9(3): 185-9.
19. Vetterlein F, Schmidt G. Effects of vasodilating agents on the microcirculation in marginal parts of the skeletal muscle. Arch Int Pharmacodyn Ther 1975 Jan; 213(1): 4-16.
20. Eringa EC, Bakker W, Smulders YM, Serne EH, Yudkin JS, Stehouwer CD. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 2007 Jun-Jul; 14(4-5): 389-402.
21. Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005 May 21-27; 365(9473): 1817-20.
22. Intaglietta M. Arteriolar vasomotion: implications for tissue ischemia. Blood Vessels 1991; 28 Suppl 1: 1-7.
23. Bouskela E. Vasomotion frequency and amplitude related to intraluminal pressure and temperature in the wing of the intact, unanesthetized bat. Microvasc Res 1989 May; 37(3): 339-51.
24. Bartlett IS, Crane GJ, Neild TO, Segal SS. Electrophysiological basis of arteriolar vasomotion in vivo. J Vasc Res 2000 Nov-Dec; 37(6): 568-75.
25. Lamboley M, Schuster A, Beny JL, Meister JJ. Recruitment of smooth muscle cells and arterial vasomotion. Am J Physiol Heart Circ Physiol 2003 Aug; 285(2): H562-9.
26. Duza T, Sarelius IH. Localized transient increases in endothelial cell Ca2+ in arterioles in situ: implications for coordination of vascular function. Am J Physiol Heart Circ Physiol 2004 Jun; 286(6): H2322-31.
27. Boedtkjer DM, Matchkov VV, Boedtkjer E, Nilsson H, Aalkjaer C. Vasomotion has chloride-dependency in rat mesenteric small arteries. Pflugers Arch 2008 Nov; 457(2): 389-404.
28. Jacobsen JC, Aalkjaer C, Nilsson H, Matchkov VV, Freiberg J, Holstein-Rathlou NH. A model of smooth muscle cell synchronization in the arterial wall. Am J Physiol Heart Circ Physiol 2007 Jul; 293(1): H229-37.
29. Jacobsen JC, Aalkjaer C, Nilsson H, Matchkov VV, Freiberg J, Holstein-Rathlou NH. Activation of a cGMP-sensitive calcium-dependent chloride channel may cause transition from calcium waves to whole cell oscillations in smooth muscle cells. Am J Physiol Heart Circ Physiol 2007 Jul; 293(1): H215-28.
30. Aalkaer C, Nilsson H. Vasomotion: cellular background for the oscillator and for the synchronization of smooth muscle cells. Br J Pharmacol 2005 Mar; 144(5): 605-16.
31. Nilsson H, Aalkjaer C. Vasomotion: mechanisms and physiological importance. Mol Interv 2003 Mar; 3(2): 79-89, 51.
32. Ursino M, Colantuoni A, Bertuglia S. Vasomotion and blood flow regulation in hamster skeletal muscle microcirculation: A theoretical and experimental study. Microvasc Res 1998 Nov; 56(3): 233-52.
33. Renaudin C, Michoud E, Rapin JR, Lagarde M, Wiernsperger N. Hyperglycaemia modifies the reaction of microvessels to insulin in rat skeletal muscle. Diabetologia 1998 Jan; 41(1): 26-33.
34. Takenaka T, Kanno Y, Kitamura Y, Hayashi K, Suzuki H, Saruta T. Role of chloride channels in afferent arteriolar constriction. Kidney Int 1996 Sep; 50(3): 864-72.
35. Pekanmaki K, Kolari PJ, Kiistala U. Laser Doppler vasomotion among patients with post-thrombotic venous insufficiency: effect of intermittent pneumatic compression. Vasa 1991; 20(4): 394-7.
36. Rucker M, Strobel O, Vollmar B, Spitzer WJ, Menger MD. Protective skeletal muscle arteriolar vasomotion during critical perfusion conditions of osteomyocutaneous flaps is not mediated by nitric oxide and endothelins. Langenbecks Arch Surg 2003 Oct; 388(5): 339-43.
37. Clark MG. Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab 2008 Oct; 295(4): E732-50.
38. Rossi M, Maurizio S, Carpi A. Skin blood flowmotion response to insulin iontophoresis in normal subjects. Microvasc Res 2005 Jul; 70(1-2): 17-22.
39. de Jongh RT, Serne EH, Rg IJ, Jorstad HT, Stehouwer CD. Impaired local microvascular vasodilatory effects of insulin and reduced skin microvascular vasomotion in obese women. Microvasc Res 2008 Mar; 75(2): 256-62.
40. Stewart JM, Taneja I, Goligorsky MS, Medow MS. Noninvasive measure of microvascular nitric oxide function in humans using very low-frequency cutaneous laser Doppler flow spectra. Microcirculation 2007 Apr-May; 14(3): 169-80.
41. de Jongh RT, Clark AD, Rg IJ, Serne EH, de Vries G, Stehouwer CD. Physiological hyperinsulinaemia increases intramuscular microvascular reactive hyperaemia and vasomotion in healthy volunteers. Diabetologia 2004 Jun; 47(6): 978-86.
42. Schmiedel O, Schroeter ML, Harvey JN. Microalbuminuria in Type 2 diabetes indicates impaired microvascular vasomotion and perfusion. Am J Physiol Heart Circ Physiol 2007 Dec; 293(6): H3424-31.
43. Jaffer U, Aslam M, Standfield N. Impaired hyperaemic and rhythmic vasomotor response in type 1 diabetes mellitus patients: a predictor of early peripheral vascular disease. Eur J Vasc Endovasc Surg 2008 May; 35(5): 603-6.
44. Rossi M, Carpi A, Galetta F, Franzoni F, Santoro G. Skin vasomotion investigation: a useful tool for clinical evaluation of microvascular endothelial function? Biomed Pharmacother 2008 Oct; 62(8): 541-5.
45. Pradhan RK, Chakravarthy VS. A computational model that links non-periodic vasomotion to enhanced oxygenation in skeletal muscle. Math Biosci 2007 Oct; 209(2): 486-99.
46. Rucker M, Strobel O, Vollmar B, Roesken F, Menger MD. Vasomotion in critically perfused muscle protects adjacent tissues from capillary perfusion failure. Am J Physiol Heart Circ Physiol 2000 Aug; 279(2): H550-8.
47. Seifert H, Jager K, Bollinger A. Analysis of flow motion by the laser Doppler technique in patients with peripheral arterial occlusive disease. Int J Microcirc Clin Exp 1988 Aug; 7(3): 223-36.
48. Christensen NJ. Spontaneous variations in resting blood flow, postischaemic peak flow and vibratory perception in the feet of diabetics. Diabetologia 1969 Jun; 5(3): 171-8.
49. Meyer MF, Rose CJ, Hulsmann JO, Schatz H, Pfohl M. Impairment of cutaneous arteriolar 0.1 Hz vasomotion in diabetes. Exp Clin Endocrinol Diabetes 2003 Apr; 111(2): 104-10.
50. Renaudin C, Michoud E, Lagarde M, Wiernsperger N. Impaired microvascular responses to acute hyperglycemia in type I diabetic rats. J Diabetes Complications 1999 Jan-Feb; 13(1): 39-44.
51. Wiernsperger N. 50years later: is metformin a vascular drug with antidiabetic properties ? Br J Diabetes Vasc Dis 2007; 7: 204-10.
52. Wiernsperger NF, Bouskela E. Microcirculation in insulin resistance and diabetes: more than just a complication. Diabetes Metab 2003 Sep; 29(4 Pt 2): 6S77-87.
53. Schubert R, Mulvany MJ. The myogenic response: established facts and attractive hypotheses. Clin Sci (Lond) 1999 Apr; 96(4): 313-26.
54. Meininger GA, Mack CA, Fehr KL, Bohlen HG. Myogenic vasoregulation overrides local metabolic control in resting rat skeletal muscle. Circ Res 1987 Jun; 60(6): 861-70.
55. Vissing SF, Secher NH, Victor RG. Mechanisms of cutaneous vasoconstriction during upright posture. Acta Physiol Scand 1997 Feb; 159(2): 131-8.
56. Vayssairat M, Tribout L, Gouny P, Gaitz JP, Baudot N, Cheynel C, et al. Importance of cutaneous postural reflex vasoconstriction in patients with atherosclerotic occlusive disease of the lower extremities. Int Angiol 1998 Mar; 17(1): 53-7.
57. Khiabani HZ, Anvar MD, Kroese AJ, Stranden E. The role of the veno-arteriolar reflex (VAR) in the pathogenesis of peripheral oedema in patients with chronic critical limb ischaemia (CLI). Ann Chir Gynaecol 2000; 89(2): 93-8.
58. Husmann M, Willenberg T, Keo HH, Spring S, Kalodiki E, Delis KT. Integrity of venoarteriolar reflex determines level of microvascular skin flow enhancement with intermittent pneumatic compression. J Vasc Surg 2008 Dec; 48(6): 1509-13.
59. Cacciatori V, Dellera A, Bellavere F, Bongiovanni LG, Teatini F, Gemma ML, et al. Comparative assessment of peripheral sympathetic function by postural vasoconstriction arteriolar reflex and sympathetic skin response in NIDDM patients. Am J Med 1997 Apr; 102(4): 365-70.
60. Golster H, Hyllienmark L, Ledin T, Ludvigsson J, Sjoberg F. Impaired microvascular function related to poor metabolic control in young patients with diabetes. Clin Physiol Funct Imaging 2005 Mar; 25(2): 100-5.
61. Belcaro G, Nicolaides AN. The venoarteriolar response in diabetics. Angiology 1991 Oct; 42(10): 827-35.
62. Rai A, Riemann M, Gustafsson F, Holstein-Rathlou NH, Torp-Pedersen C. Streptozotocin-induced diabetes decreases conducted vasoconstrictor response in mouse cremaster arterioles. Horm Metab Res 2008 Sep; 40(9): 651-4.
63. Shore AC, Price KJ, Sandeman DD, Tripp JH, Tooke JE. Posturally induced vasoconstriction in diabetes mellitus. Arch Dis Child 1994 Jan; 70(1): 22-6.
64. Wiernsperger NF. In defense of microvascular constriction in diabetes. Clin Hemorheol Microcirc 2001; 25(2): 55-62.
65. Sarelius IH, Kuebel JM, Wang J, Huxley VH. Macromolecule permeability of in situ and excised rodent skeletal muscle arterioles and venules. Am J Physiol Heart Circ Physiol 2006 Jan; 290(1): H474-80.
66. Fu BM, Chen B, Chen W. An electrodiffusion model for effects of surface glycocalyx layer on microvessel permeability. Am J Physiol Heart Circ Physiol 2003 Apr; 284(4): H1240-50.
67. Noble MI, Drake-Holland AJ, Vink H. Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process. QJM 2008 Jul; 101(7): 513-8.
68. Perrin RM, Harper SJ, Bates DO. A role for the endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus. Cell Biochem Biophys 2007; 49(2): 65-72.
69. Dell'Omo G, Penno G, Pucci L, Mariani M, Del Prato S, Pedrinelli R. Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome. Atherosclerosis 2004 Feb; 172(2): 383-9.
70. Minshall RD, Malik AB. Transport across the endothelium: regulation of endothelial permeability. Handb Exp Pharmacol 2006(176 Pt 1): 107-44.
71. Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo M, Kargozaran H, et al. Microvascular permeability in diabetes and insulin resistance. Microcirculation 2007 Jun-Jul; 14(4-5): 363-73.
72. Michel CC, Curry FE. Microvascular permeability. Physiol Rev 1999 Jul; 79(3): 703-61.
73. Moan A, Nordby G, Os I, Birkeland KI, Kjeldsen SE. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism 1994 Apr; 43(4): 423-7.
74. Brun JF, Aloulou I, Varlet-Marie E. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia? Clin Hemorheol Microcirc 2004; 30(3-4): 203-9.
75. Sola E, Vaya A, Simo M, Hernandez-Mijares A, Morillas C, Espana F, et al. Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance. Clin Hemorheol Microcirc 2007; 37(4):.
76. McHedlishvili G, Varazashvili M, Gobejishvili L. Local RBC aggregation disturbing blood fluidity and causing stasis in microvessels. Clin Hemorheol Microcirc 2002; 26(2): 99-106.
77. Minetti M, Agati L, Malorni W. The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res 2007 Jul 1; 75(1): 21-8.
78. Sprague RS, Stephenson AH, Ellsworth ML. Red not dead: signaling in and from erythrocytes. Trends Endocrinol Metab 2007 Nov; 18(9): 350-5.
79. Anichkov DA, Maksina AG, Shostak NA. Relationships between erythrocyte membrane properties and components of metabolic syndrome in women. Med Sci Monit 2005 Apr; 11(4): CR203-10.
80. Justo D, Marilus R, Mardi T, Tolchinsky T, Goldin Y, Rozenblat M, et al. The appearance of aggregated erythrocytes in the peripheral blood of individuals with insulin resistance. Diabetes Metab Res Rev 2003 Sep-Oct; 19(5): 386-91.
81. Kaul DK, Koshkaryev A, Artmann G, Barshtein G, Yedgar S. Additive effect of red blood cell rigidity and adherence to endothelial cells in inducing vascular resistance. Am J Physiol Heart Circ Physiol 2008 Oct; 295(4): H1788-93.
82. Yalcin O, Uyuklu M, Armstrong JK, Meiselman HJ, Baskurt OK. Graded alterations of RBC aggregation influence in vivo blood flow resistance. Am J Physiol Heart Circ Physiol 2004 Dec; 287(6): H2644-50.
83. Aloulou I, Varlet-Marie E, Mercier J, Brun JF. Hemorheological disturbances correlate with the lipid profile but not with the NCEP-ATPIII score of the metabolic syndrome. Clin Hemorheol Microcirc 2006; 35(1-2): 207-12.
84. Aloulou I, Varlet-Marie E, Mercier J, Brun JF. The hemorheological aspects of the metabolic syndrome are a combination of separate effects of insulin resistance, hyperinsulinemia and adiposity. Clin Hemorheol Microcirc 2006; 35(1-2): 113-9.
85. Sola E, Vaya A, Corella D, Santaolaria ML, Espana F, Estelles A, et al. Erythrocyte hyperaggregation in obesity: determining factors and weight loss influence. Obesity (Silver Spring) 2007 Aug; 15(8): 2128-34.
86. Rucker M, Schafer T, Scheuer C, Harder Y, Vollmar B, Menger MD. Local heat shock priming promotes recanalization of thromboembolized microvasculature by upregulation of plasminogen activators. Arterioscler Thromb Vasc Biol 2006 Jul; 26(7): 1632-9.
87. Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 2002 Oct 29; 106(18): 2372-8.
88. Kraja AT, Province MA, Arnett D, Wagenknecht L, Tang W, Hopkins PN, et al. Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? Nutr Metab (Lond) 2007; 4: 28.
89. Lindahl B, Asplund K, Eliasson M, Evrin PE. Insulin resistance syndrome and fibrinolytic activity: the northern Sweden MONICA study. Int J Epidemiol 1996 Apr; 25(2): 291-9.
90. Scelles V, Raccah D, Alessi MC, Vialle JM, Juhan-Vague I, Vague P. Plasminogen activator inhibitor 1 and insulin levels in various insulin resistance states. Diabete Metab 1992 Jan-Feb; 18(1): 38-42.
91. Westrick RJ, Eitzman DT. Plasminogen activator inhibitor-1 in vascular thrombosis. Curr Drug Targets 2007 Sep; 8(9): 966-1002.
92. Gurlek A, Bayraktar M, Kirazli S. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels. Diabetes Care 2000 Jan; 23(1): 88-92.
93. Bastard JP, Pieroni L, Hainque B. Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab Res Rev 2000 May-Jun; 16(3): 192-201.
94. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 1997 Jul; 78(1): 656-60.
95. Fitzgerald SM, Bashari H, Cox JA, Parkington HC, Evans RG. Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo. Am J Physiol Heart Circ Physiol 2007 Aug; 293(2): H1072-82.
96. Katakam PV, Hoenig M, Ujhelyi MR, Miller AW. Cytochrome P450 activity and endothelial dysfunction in insulin resistance. J Vasc Res 2000 Sep-Oct; 37(5): 426-34.
97. Triggle CR, Ding H, Anderson TJ, Pannirselvam M. The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes. Mol Cell Biochem 2004 Aug; 263(1-2): 21-7.
98. Kohler R, Hoyer J. The endothelium-derived hyperpolarizing factor: insights from genetic animal models. Kidney Int 2007 Jul; 72(2): 145-50.
99. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 1996 Nov; 28(5): 703-11.
100. Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clin Exp Pharmacol Physiol 2004 Sep; 31(9): 641-9.
101. Park Y, Capobianco S, Gao X, Falck JR, Dellsperger KC, Zhang C. Role of EDHF in type 2 diabetesinduced endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008 Nov; 295(5): H1982-8.
102. Folgering JH, Sharif-Naeini R, Dedman A, Patel A, Delmas P, Honore E. Molecular basis of the mammalian pressure-sensitive ion channels: focus on vascular mechanotransduction. Prog Biophys Mol Biol 2008 Jun-Jul; 97(2-3): 180-95.
103. Gautam M, Gojova A, Barakat AI. Flow-activated ion channels in vascular endothelium. Cell Biochem Biophys 2006; 46(3): 277-84. 309-18.
104. Jentsch TJ, Stein V, Weinreich F, Zdebik AA. Molecular structure and physiological function of chloride channels. Physiol Rev 2002 Apr; 82(2): 503-68.
105. McGahon MK, Needham MA, Scholfield CN, McGeown JG, Curtis TM. Ca2+-activated Cl- current in retinal arteriolar smooth muscle. Invest Ophthalmol Vis Sci 2009 Jan; 50(1): 364-71.
106. Bouskela E, Grampp W, Mellander S. Effects of hypertonic NaCl solution on microvascular haemodynamics in normo- and hypovolaemia. Acta Physiol Scand 1990 Sep; 140(1): 85-94.
107. Velasco IT, Pontieri V, Rocha e Silva M, Jr., Lopes OU. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol 1980 Nov; 239(5): H664-73.
108. Eriksson E, Lisander B. Low flow states in the microvessels of skeletal muscle in cat. Acta Physiol Scand 1972 Oct; 86(2): 202-10.
109. Torres Filho IP, Boegehold MA, Bouskela E, House SD, Johnson PC. Microcirculatory responses in cat sartorius muscle to hemorrhagic hypotension. Am J Physiol 1989 Nov; 257(5 Pt 2): H1647-55.
110. Hutchins PM, Goldstone J, Wells R. Effects of hemorrhagic shock on the microvasculature of skeletal muscle. Microvasc Res 1973 Mar; 5(2): 131-40.
111. Harris PD, Greenwald EK, Nicoll PA. Neural mechanisms in small vessel response to hemorrhage in the unanesthetized bat. Am J Physiol 1970 Feb; 218(2): 560-5.
112. Colantuoni A, Bertuglia S, Intaglietta M. Microvessel diameter changes during hemorrhagic shock in unanesthetized hamsters. Microvasc Res 1985 Sep; 30(2): 133-42.
113. Zakaria el R, Tsakadze NL, Garrison RN. Hypertonic saline resuscitation improves intestinal microcirculation in a rat model of hemorrhagic shock. Surgery 2006 Oct; 140(4): 579-87; discussion 87-8.
114. Gray SD. Microscopic observation of skeletal muscle vascular responses to vasopressors during severe hemorrhagic hypotension. J Trauma 1972 Feb; 12(2): 147-60.
115. Zhao KS, Junker D, Delano FA, Zweifach BW. Microvascular adjustments during irreversible hemorrhagic shock in rat skeletal muscle. Microvasc Res 1985 Sep; 30(2): 143-53.
116. Boegehold MA, Johnson PC. Response of arteriolar network of skeletal muscle to sympathetic nerve stimulation. Am J Physiol 1988 May; 254(5 Pt 2): H919-28.
117. Mazzoni MC, Borgstrom P, Intaglietta M, Arfors KE. Lumenal narrowing and endothelial cell swelling in skeletal muscle capillaries during hemorrhagic shock. Circ Shock 1989 Sep; 29(1): 27-39.
118. Victorino GP, Newton CR, Curran B. Effect of hypertonic saline on microvascular permeability in the activated endothelium. J Surg Res 2003 Jun 1; 112(1): 79-83.
119. Wiernsperger NF. Metformin: intrinsic vasculoprotective properties. Diabetes Technol Ther 2000 Summer; 2(2): 259-72.
120. Bouskela E, Cyrino FZ, Wiernsperger N. Effects of insulin and the combination of insulin plus metformin (glucophage) on microvascular reactivity in control and diabetic hamsters. Angiology 1997 Jun; 48(6): 503-14.
121. Gaskin FS, Kamada K, Yusof M, Durante W, Gross G, Korthuis RJ. AICAR preconditioning prevents postischemic leukocyte rolling and adhesion: role of K(ATP) channels and heme oxygenase. Microcirculation 2009 Feb; 16(2): 167-76.
122. Fujii N, Ho RC, Manabe Y, Jessen N, Toyoda T, Holland WL, et al. Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes 2008 Nov; 57(11): 2958-66.
123. Hardie DG. Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett 2008 Jan 9; 582(1): 81-9.
124. Grant PJ. Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes Metab 2003 Sep; 29(4 Pt 2): 6S44-52.
125. Mamputu JC, Wiernsperger NF, Renier G. Antiatherogenic properties of metformin: the experimental evidence. Diabetes Metab 2003 Sep; 29(4 Pt 2): 6S71-6.
126. Scheen AJ, Paquot N, Lefebvre PJ. [United Kingdom Prospective Diabetes Study (UKPDS): 10 years later]. Rev Med Liege 2008 Oct; 63(10): 624-9.
127. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008 Oct 9; 359(15): 1577-89.
128. Dhindsa M, Sommerlad SM, DeVan AE, Barnes JN, Sugawara J, Ley O, et al. Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity. J Appl Physiol 2008 Aug; 105(2): 427-32.
129. Gori T, Di Stolfo G, Sicuro S, Dragoni S, Lisi M, Parker JD, et al. Correlation analysis between different parameters of conduit artery and microvascular vasodilation. Clin Hemorheol Microcirc 2006; 35(4): 509-15.
130. Kullo IJ, Malik AR, Santos S, Ehrsam JE, Turner ST. Association of cardiovascular risk factors with microvascular and conduit artery function in hypertensive subjects. Am J Hypertens 2007 Jul; 20(7): 735-42.
131. Meyer MF, Lieps D, Schatz H, Pfohl M. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction. Microvasc Res 2008 May; 76(1): 61-5.
132. Title LM, Lonn E, Charbonneau F, Fung M, Mather KJ, Verma S, et al. Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome. Vasc Med 2008 Nov; 13(4): 263-70.
133. Ren G, Michael LH, Entman ML, Frangogiannis NG. Morphological characteristics of the microvasculature in healing myocardial infarcts. J Histochem Cytochem 2002 Jan; 50(1): 71-9.
134. Sambuceti G, L'Abbate A, Marzilli M. Why should we study the coronary microcirculation? Am J Physiol Heart Circ Physiol 2000 Dec; 279(6): H2581-4.
135. Urbancic-Rovan V, Bernjak A, Stefanovska A, Azman-Juvan K, Kocijancic A. Macro- and microcirculation in the lower extremities--possible relationship. Diabetes Res Clin Pract 2006 Aug; 73(2): 166-73.
136. Lockhart CJ, Hamilton PK, Quinn CE, McVeigh GE. End-organ dysfunction and cardiovascular outcomes: the role of the microcirculation. Clin Sci (Lond) 2009 Feb; 116(3): 175-90.
137. Krentz AJ, Clough G, Byrne CD. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab 2007 Nov; 9(6): 781-91.
138. Stokes KY, Granger DN. The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia? J Physiol 2005 Feb 1; 562(Pt 3): 647-53.
139. Abularrage CJ, Sidawy AN, Aidinian G, Singh N, Weiswasser JM, Arora S. Evaluation of the microcirculation in vascular disease. J Vasc Surg 2005 Sep; 42(3): 574-81.